Suvretta Capital Management, LLC Fulcrum Therapeutics, Inc. Transaction History
Suvretta Capital Management, LLC
- $3.33 Billion
- Q3 2025
A detailed history of Suvretta Capital Management, LLC transactions in Fulcrum Therapeutics, Inc. stock. As of the latest transaction made, Suvretta Capital Management, LLC holds 5,381,000 shares of FULC stock, worth $46.7 Million. This represents 1.41% of its overall portfolio holdings.
Number of Shares
5,381,000
Previous 5,082,900
5.86%
Holding current value
$46.7 Million
Previous $35 Million
34.18%
% of portfolio
1.41%
Previous 1.2%
Shares
18 transactions
Others Institutions Holding FULC
# of Institutions
133Shares Held
55.4MCall Options Held
176KPut Options Held
13.5K-
Ra Capital Management, L.P. Boston, MA10.2MShares$88.7 Million1.53% of portfolio
-
Tcg Crossover Management, LLC Palo Alto, CA5.25MShares$45.5 Million5.13% of portfolio
-
Black Rock Inc. New York, NY4.8MShares$41.6 Million0.0% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT4.67MShares$40.5 Million1.65% of portfolio
-
Vanguard Group Inc Valley Forge, PA3MShares$26 Million0.0% of portfolio
About Fulcrum Therapeutics, Inc.
- Ticker FULC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,038,900
- Market Cap $451M
- Description
- Fulcrum Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing products for improving the lives of patients with genetically defined diseases in the areas of high unmet medical need in the United States. Its product candidates are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystro...